Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy

被引:204
作者
Maron, BJ
Carney, KP
Lever, HM
Lewis, JF
Barac, I
Casey, SA
Sherrid, MV
机构
[1] Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[3] Univ Florida, Hlth Sci Ctr, Gainesville, FL USA
[4] St Lukes Roosevelt Hosp, New York, NY USA
关键词
D O I
10.1016/S0735-1097(02)02976-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The goal of this study was to determine the impact of race on identification of hypertrophic cardiomyopathy (HCM). BACKGROUND Sudden death in young competitive athletes is due to a variety of cardiovascular diseases (CVDs) and, most commonly, HCM. These catastrophes have become an important issue for African Americans, although HCM has been previously regarded as rare in this segment of the U.S. population. METHODS We studied the relationship of race to the prevalence of CVDs causing sudden death in our national athlete registry, and compared these findings with a representative multicenter hospital-based cohort of patients with HCM. RESULTS Of 584 athlete deaths, 286 were documented to be due to CVD at ages 17 3 years; 156 (55%) were white, and 120 (42%) were African American. Most were male (90%), and 67% participated in basketball and football. Among the 286 cardiovascular deaths, most were due to HCM (n = 102; 36%) or anomalous coronary artery of wrong sinus origin (n = 37; 13%). Of the athletes who died of HCM, 42 (41%) were white, but 56 (55%) were African American. In contrast, of 1,986 clinically identified HCM patients, only 158 (8%) were African American (p < 0.001). CONCLUSIONS In this autopsy series, HCM represented a common cause of sudden death in young and previously undiagnosed African American male athletes, in sharp contrast with the infrequent clinical identification of HCM in a hospital-based population (i.e., by seven-fold). This discrepancy suggests that many HCM cases go unrecognized in the African American community, underscoring the need for enhanced clinical recognition of HCM to create the opportunity for preventive measures to be employed in high-risk patients with this complex disease. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:974 / 980
页数:7
相关论文
共 44 条
[31]   RACIAL VARIATION IN CARDIAC PROCEDURE USE AND SURVIVAL FOLLOWING ACUTE MYOCARDIAL-INFARCTION IN THE DEPARTMENT-OF-VETERANS-AFFAIRS [J].
PETERSON, ED ;
WRIGHT, SM ;
DALEY, J ;
THIBAULT, GE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (15) :1175-1180
[32]   Preparticipation cardiovascular screening for US collegiate student-athletes [J].
Pfister, GC ;
Puffer, JC ;
Maron, BJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (12) :1597-+
[33]  
ROBERTS CS, 1989, PROGR CARDIOLOGY, V2, P3
[34]   CONGENITAL HYPOPLASIA OF BOTH RIGHT AND LEFT CIRCUMFLEX CORONARY-ARTERIES [J].
ROBERTS, WC ;
GLICK, BN .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (01) :121-123
[35]   The effect of race and sex on physicians' recommendations for cardiac catheterization [J].
Schulman, KA ;
Berlin, JA ;
Harless, W ;
Kerner, JF ;
Sistrunk, S ;
Gersh, BJ ;
Dubé, R ;
Taleghani, CK ;
Burke, JE ;
Williams, S ;
Eisenberg, JM ;
Escarce, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (08) :618-626
[36]   MOLECULAR-BASIS OF FAMILIAL CARDIOMYOPATHIES [J].
SCHWARTZ, K ;
CARRIER, L ;
GUICHENEY, P ;
KOMAJDA, M .
CIRCULATION, 1995, 91 (02) :532-540
[37]  
TANAKA M, 1986, BRIT HEART J, V55, P575
[38]   RIGHT VENTRICULAR CARDIOMYOPATHY AND SUDDEN-DEATH IN YOUNG-PEOPLE [J].
THIENE, G ;
NAVA, A ;
CORRADO, D ;
ROSSI, L ;
PENNELLI, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (03) :129-133
[39]  
VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641
[40]   THE SPECTRUM OF SYMPTOMS AND QT INTERVALS IN CARRIERS OF THE GENE FOR THE LONG-QT SYNDROME [J].
VINCENT, GM ;
TIMOTHY, KW ;
LEPPERT, M ;
KEATING, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (12) :846-852